Verastem Oncology

(NASDAQ: VSTM)
Healthcare  |  Biotechnology
1.41 -0.18 -11.32%
Stock Price | July 19, 2019, 3:59 p.m.
0 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 1.59
52 Week Low: 1.16
52 Week High: 10.35
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Verastem Inc is a part of the healthcare sector. It is focused on discovering and developing drugs to aid patients suffering from cancer. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. The company is engaged in running clinical trials in cancers where there are limited treatment options, including lung, ovarian, lymphoma, pancreatic and other advanced cancers.

Read more Read less

Recently Viewed Tickers

Premium Stock Watchlist 11/04/2015

3 years ago

Premium Stock Watchlist 11/02/2015

3 years ago

Premium Stock Watchlist 10/15/2015

3 years ago

Premium Stock Watchlist Video 08/13/2015

3 years ago

Premium Stock Watchlist 08/12/2015

3 years ago

Free Top 10 Stocks Corporate Insiders Are Buying Heavily This Week

4 years ago

Free Top 10 Stocks Corporate Insiders Are Buying Heavily This Week

4 years ago

Free Stocks On My Radar This Week - 1/12/15

4 years ago